ArticlePloS one2018

Discovery of novel multidrug resistance protein 4 (MRP4) inhibitors as active agents reducing resistance to anticancer drug 6-Mercaptopurine (6-MP) by structure and ligand-based virtual screening.

Ya Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.